Greenberg, Benjamin <br/><br/>
Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate.  [electronic resource] 

 -  Current medical research and opinion  07 2020 
 - 1167-1175 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1080/03007995.2020.1760808  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Female<br/>Glatiramer Acetate--therapeutic use<br/>Health Care Costs<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Recurrence<br/>Retrospective Studies